Julian Hickling

Molten Metal Technology, Inc. is an environmental technology company which engages in the commercialization and continued development of its innovative, proprietary processing technology known as Catalytic Extraction Processing. The core of CEP is a molten metal bath operating into which feedstocks and selected chemicals can be introduced. The catalytic and solvent effect of the molten metal bath causes feedstocks to break down into their constituent elements and dissolve into the molten metal. In addition of various selected chemicals to the molten metal allows feedstocks to reform and be recovered as different materials which generally can be re-used as a raw material by the feedstock generator or can be sold to other users. The CEP system largely consists of process, instrument and control components currently used widely in the metallurgical and chemical industries. The company was founded in 1989 and is headquartered in Fall River, MA.

Apax Partners LLP engages in providing investment services. It focuses on investing in firms across the global sectors such as technology and telecommunications, services, healthcare, and consumer. The company was founded by Ronald Mourad Cohen and Alan J. Patricof in 1969 and is headquartered in London, the United Kingdom.

Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia.

PA Consulting Group Ltd. engages in the provision of management, systems, technology consulting, and innovation services. The company was founded by Ernest Button on September 3, 2015 and is headquartered in London, the United Kingdom.

Part of Abbott Laboratories, Amrad ICT is an Australian company that manufactures point-of-care diagnostic tests. The company is based in Sydney, Australia. Amrad ICT was acquired by Binax, Inc. /Old/ from CSL Innovation Pty Ltd. on September 15, 2000.

Part of Merck KGaA, AMRAD Biotech is an Australian company that develops biotechnology reagents and antibodies. The company is based in Boronia, Australia. AMRAD Biotech was acquired by CHEMICON International, Inc. from CSL Innovation Pty Ltd. on December 08, 1999 for $8.92 million.

UniQuest Pty Ltd. operates as a commercialization company of The University of Queensland. It specializes in industry-university collaborations, global technology transfer, and provide access to UQ's world-class expertise, intellectual property, and facilities. The company was founded in July 1984 and is headquartered in Brisbane, Australia.

Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia.

Princess Alexandra Hospital NHS Trust provides hospital services. The non-profit company is based in Essex, UK. Lance McCarthy has been the CEO of the British company since 2017.

Universal Biosensors Pty Ltd. manufactures diagnostic test systems. Its products include blood glucose monitoring and coagulation testing. The company was founded in 2001 and is headquartered in Rowville, Australia.

Neurotide is a spin-off company from The University of Queensland's commercial arm, UniQuest Pty Ltd. The company's research is led by UQ's Professor Istvan Toth and Dr Joanne Blanchfield, who are creating an oral pharmaceutical for pain. They are demonstrating that the drug can relieve pain in vivo. If this research is successful, the company will move towards human trials. Investors are sought to help them continue development. They hope to access the international market for pain drugs, and are particularly targeting the neuropathic pain market.

QIMR Berghofer Medical Research Institute is a successful medical research institute in Australia that was established 75 years ago by the Queensland government. QIMR Berghofer is based in Herston, Australia. The institute focuses on improving health by developing new diagnostics, better treatments, and prevention strategies for cancer, infectious diseases, mental health, and chronic disorders. QIMR Berghofer collaborates with clinicians and other research institutes and has an active program for patenting and commercializing technologies. The institute is home to approximately 1000 scientists, students, and support staff. It has made significant contributions to the field of inflammation biology, chronic disorders, and the development of vaccines for diseases such as Zika, Ebola, and COVID-19.

The American Society of Law, Medicine & Ethics operates an organization that provides scholarship, debate, and critical thought for professionals. The non-profit company is based in Boston, MA. The company was founded by John A. Norris.

United Drugs, Inc. owns and operates pharmacies. It offers health services and screenings, durable medical equipment, retail items and prescription filling services. The company was founded in 1976 and is headquartered in Phoenix, AZ.

Part of Emkado Ltd., York Medical Technologies Ltd. is a company that distributes surgical instruments and disposable products. The company is based in York, UK. York Medical Technologies was acquired by Emkado Ltd. on September 24, 2014. The British company was founded by Dean Moss.

AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008.

St. Vincent's Hospital Sydney Pty Ltd. provides health services. It offers cardiology, dental, endocrinology, audiology, mental health, medicine, sacred heart health services, urology, and vascular surgery. The company was founded in 1857 and is headquartered in Darlinghurst, Australia.

The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia.

Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia.

Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia.

MiReven Pty Ltd. operates as an Australian biopharmaceutical company. The private company is based in Nedlands, Australia.

Clinical Genomics Technologies Pty Ltd. manufactures and sells healthcare solutions for the early detection and prevention of disease. The company was founded by Lawrence LaPointe, Richard J. Sands and Susanne K. Pedersen in September 2006 and is headquartered in North Ryde, Australia.

QUE Oncology, Inc. engages in preventing and treating life-threatening cancers such as prostate cancer, breast cancer, melanoma, and cancer pain; and related conditions. The company is headquartered in Atlanta, GA.

MecRx Pty Ltd. develops drugs for treatment of cancer. The company was founded by Ian Holmes, Jo Alcindor, Tom Peat and Janet Newman in 2013 and is headquartered in Melbourne, Australia.

OncoRes Medical Pty Ltd. develops an imaging medical device which provides micro-scale images of tissue stiffness and elasticity information to surgeons. The company is headquartered in Nedlands, Australia.

Longas Technologies Pty Ltd. is engaged in developing next generation sequencing (NGS) technologies. The company was founded by Ian Charles, Aaron Darling, and Catherine Burke in 2015 and is headquartered in Sydney, Australia.

Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom.